Paloma Pharmaceuticals palomapharma.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180) Eye Health (703)

Paloma Pharmaceuticals, Inc. is a drug development company focusing on pathologies with a vascular component including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (pulmonary fibrosis) endometriosis, osteoporosis and skin diseases (psoriasis and atopic dermatitis). Paloma owns the intellectual property relating to a series of , small molecule drugs created through an integrated design platform incorporating , customized and industry standa...Show all

Paloma Pharmaceuticals, Inc. is a drug development company focusing on pathologies with a vascular component including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (pulmonary fibrosis) endometr...Show all

Company (Alive / Active)

Phone:

Fax:

37 Neillian Crescent
Jamaica Plain, 02130
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Paloma Pharmaceuticals $0.5M Sep 7, 2009
See all 27 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Paloma Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors

Competitors

Company Status Description Investors

Cardiac Pathways

Sunnyvale, California, United States
AcquiredCardiac Pathways manufactures minimally invasive systems used by electrophysiologists to diagnose and treat cardiac tachyarrhythmias, which if untreated can cause palpitations, fainting, and sudden cardiac arrest. Cardiac Pathways' products consist principally of systems for performing ablation treatment and for diagnostic mapping.Login to see details

NeuroGenomeX

Madison, Wisconsin, United States
Alive / ActiveNeuroGenomeX is a drug discovery company developing novel treatments for diseases of the brain and nervous system. The current NeuroGenomeX discovery program is focused on therapeutic target areas of epilepsy and traumatic brain injury. NeuroGenomeX is advancing its lead drug candidate, 2-deoxy-D-glucose (2DG), as an anticonvulsant that stops seizures and has beneficial effects against adverse long-term consequences of epilepsy. 2DG also has shown favorable therapeutic neuroprotective effects in...Show allLogin to see details
See all 27 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis Jul 01, 2015 Sep 26, 2017 Patent
Water heater attachment method and water heater attachment structure Jan 21, 2015 Apr 18, 2017 Patent
Radiation countermeasure agents Feb 16, 2012 Jul 05, 2016 Patent
Rich-lean burner Feb 01, 2012 Jul 28, 2015 Patent
Rich-lean burner Apr 03, 2013 Jul 21, 2015 Patent
See all 14 patents